常见放射治疗程序商业价格的决定因素
该研究利用美国2096家提供放疗的医院上报的商业价格数据,分析4种常见放疗程序的定价差异及相关市场因素。结果显示,医院内不同保险公司支付的价格相差2.3至2.5倍,区域间中位价格相差2.4至3.2倍;营利性、教学医院及大型健康系统附属医院价格更高,而放疗实践整合程度与价格无显著关联。
要点
- 医院内不同私人保险公司的支付价格平均相差2.3至2.5倍。
- 区域间第90百分位医院的中位价格是第10百分位的2.4至3.2倍。
- 营利性、教学及大型健康系统附属医院的价格通常更高。
核心结论
- 常见放疗程序的商业价格因患者所选私人保险公司和医院不同而相差2倍以上。
- 营利性医院、教学医院及附属大型健康系统的医院更可能出现较高价格。
- 放疗实践整合程度与任何程序的价格均无显著关联。
研究设计与样本
- 基于美国医疗保险服务提供者文件(Medicare Provider of Service file)中2096家提供放疗的医院,分析私人保险公司对4种常见放疗程序支付的商业价格。
- 评估医院内第90百分位与第10百分位价格比值及区域间第90与第10百分位医院的中位价格比值。
- 建立多变量模型检验医院、健康系统、区域及市场因素与医院中位商业价格的关联。
主要发现
- 1004家医院(47.9%)报告了4种放疗程序中至少1种的商业价格。
- 调强放疗(IMRT)计划与IMRT实施的全国中位商业价格分别为4073美元(四分位距[IQR],2242-6305美元)和1666美元(IQR,1014-2619美元)。
- 三维放疗(3D-RT)计划与3D-RT实施的价格分别为2824美元(IQR,1339-4738美元)和616美元(IQR,419-877美元)。
- 医院内私人保险公司支付的第90百分位价格平均为第10百分位价格的2.3至2.5倍,具体取决于程序。
- 每个医院转诊区域内,第90百分位医院的中位价格是第10百分位医院的2.4至3.2倍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Using hospital-reported price data, we analyzed whether various market factors including radiation oncology practice consolidation were associated with higher commercial prices for radiation therapy (RT). METHODS AND MATERIALS: We evaluated commercial prices paid by private insurers for 4 common RT procedures-intensity modulated RT (IMRT) planning, IMRT delivery, 3-dimensional RT (3D-RT) planning, and 3D-RT delivery-reported among the 2096 hospitals in the United States that deliver RT according to the Medicare Provider of Service file. To assess price variation within hospitals, we evaluated the ratio of the 90th percentile price to the 10th percentile price among different private insurers. To assess regional variation, we similarly compared median commercial prices at the 90th and 10th percentile hospitals in each Hospital Referral Region. We generated multivariable models to test the association of various hospital, health system, regional, and market factors on median hospital commercial prices. RESULTS: A total of 1004 hospitals (47.9%) reported at least 1 commercial price for any of the 4 RT procedures considered in this study. National median commercial prices for IMRT planning and IMRT delivery were $4073 (interquartile ratio [IQR], $2242-$6305) and $1666 (IQR, $1014-$2619), respectively. Prices for 3D-RT planning and 3D-RT delivery were $2824 (IQR, $1339-$4738) and $616 (IQR, $419-877), respectively. Within hospitals, the 90th percentile price paid by a private insurer was 2.3 to 2.5 times higher on average than the 10th percentile price, depending on the procedure. Within each Hospital Referral Region, the median price at the 90th percentile hospital was between 2.4 and 3.2 times higher than at the 10th percentile hospital. On multivariable analysis, higher prices were generally observed at hospitals with for-profit ownership, teaching status, and affiliation with large health systems. Levels of radiation oncology practice consolidation were not significantly associated with any prices. CONCLUSIONS: Commercial prices for common RT procedures vary by more than a factor of 2 depending on a patient's private insurer and hospital of choice. Higher prices were more likely to be found at for-profit hospitals, teaching hospitals, and hospitals affiliated with large health systems.
引用
- Milligan MG, Orav EJ, Lam MB, et al. Determinants of Commercial Prices for Common Radiation Therapy Procedures. Int J Radiat Oncol Biol Phys. 2022. PMID: 36309073. doi:10.1016/j.ijrobp.2022.04.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。